G. Jones

A phase I dose finding and biomarker study of TKI258 (dovitinib lactate) in patients with advanced melanoma

J. Kirkwood, P. Hwu, H. Rupani, 2008 .

Modelling TKI258 exposure and biomarker response in support of phase I dosing schedule finding

M. Shi, X. Wang, H. Schran, 2008 .

Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy.

A. Lipton, K. Hopper, H. Harvey, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acyclovir and vidarabine monophosphate: comparison of iontophoretic and intravenous administration for the treatment of HSV-1 stromal keratitis.

D. S. Hull, I. Whang, Y. Shimomura, 1982, The American journal of medicine.

A phase II study to evaluate the feasibility of bi-weekly docetaxel followed by bi-weekly doxorubicin and cyclophosphamide as adjuvant therapy for operable breast cancer (T-AC)

G. Jones, R. Smith, R. Lambert-Falls, 2004 .

A phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma.

M. Citron, D. Levitt, J. Zeffren, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis

Jason R. Rodgers, Douglas N. Warrington, D. de la Iglesia-Garcia, 2016, Gut.

Bone levels of cephradine and cefuroxime after intravenous administration in patients undergoing total hip replacement

T. J. Cain, P. Woods, G. Jones, 2004, International Orthopaedics.

Effect of TKI258 on plasma biomarkers and pharmcokinetics in patients with advanced melanoma.

J. Kirkwood, M. Motwani, M. Shi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.